{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:51:50Z","timestamp":1792036310804,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.nbd.2007.05.003","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T03:45:12Z","timestamp":1179978312000},"page":"265-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Glycolipid and ganglioside metabolism imbalances in Huntington's disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Paula A.","family":"Desplats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A.","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi E.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Gilmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gregor","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Seyfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2007.05.003_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0003-2697(78)90373-1","article-title":"High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species","volume":"89","author":"Ando","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.wnn.0000152205.79033.73","article-title":"White matter volume and cognitive dysfunction in early Huntington's disease","volume":"18","author":"Beglinger","year":"2005","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.nbd.2007.05.003_bib3","first-page":"463","article-title":"Brain gangliosides in Huntington's disease","volume":"23","author":"Bernheimer","year":"1979","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.nbd.2007.05.003_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.17.2.172","article-title":"Biochemical studies in Huntington's chorea: VI. Composition of striatal neutral lipids, phospholipids, glycolipids, fatty acids, and amino acids","volume":"17","author":"Borri","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.05.003_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.nbd.2007.05.003_bib6","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2007.05.003_bib7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.cdd.4401834","article-title":"Gangliosides as apoptotic signals in ER stress response","volume":"13","author":"d'Azzo","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2007.05.003_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jnr.20798","article-title":"Influence of caloric restriction on motor behavior, longevity, and brain lipid composition in Sandhoff disease mice","volume":"83","author":"Denny","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1471-4159.2005.03588.x","article-title":"Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease","volume":"96","author":"Desplats","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2007.05.003_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1534582306289367","article-title":"Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells","volume":"5","author":"Dunbar","year":"2006","journal-title":"Behav. Cogn. Neurosci. Rev."},{"key":"10.1016\/j.nbd.2007.05.003_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","article-title":"In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease","volume":"63","author":"Fennema-Notestine","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.05.003_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.803227","article-title":"Deficient ganglioside biosynthesis: a novel human sphingolipidosis","volume":"187","author":"Fishman","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.nbd.2007.05.003_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/B:BIGI.0000034429.55418.71","article-title":"Inheritance of lysosomal acid beta-galactosidase activity and gangliosides in crosses of DBA\/2J and knockout mice","volume":"42","author":"Hauser","year":"2004","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.nbd.2007.05.003_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00238752","article-title":"Striatal ganglioside levels in the rat following kainic acid lesions: comparison with Huntington's disease","volume":"44","author":"Higatsberger","year":"1981","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington's disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2007.05.003_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2007.05.003_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.18.4.408","article-title":"Biochemical studies in Huntington's chorea: VII. The lipid composition of the cerebral white and gray matter","volume":"18","author":"Hooghwinkel","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2007.05.003_bib19","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1093\/nar\/gng015","article-title":"Summaries of Affymetrix GeneChip probe level data","volume":"31","author":"Irizarry","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1194\/jlr.M400411-JLR200","article-title":"Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice","volume":"46","author":"Kasperzyk","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0887-8994(92)90361-2","article-title":"Dysmyelinogenesis in animal model of GM1 gangliosidosis","volume":"8","author":"Kaye","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.nbd.2007.05.003_bib22","doi-asserted-by":"crossref","first-page":"36464","DOI":"10.1074\/jbc.M503672200","article-title":"Huntingtin associates with acidic phospholipids at the plasma membrane","volume":"280","author":"Kegel","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.05.003_bib23","doi-asserted-by":"crossref","first-page":"19457","DOI":"10.1074\/jbc.271.32.19457","article-title":"Characterization of mouse ST8Sia II (STX) as a neural cell adhesion molecule-specific polysialic acid synthase. Requirement of core alpha1,6-linked fucose and a polypeptide chain for polysialylation","volume":"271","author":"Kojima","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.05.003_bib24","series-title":"Lysosomal Glycosphingolipid Storage Diseases","author":"Kolter","year":"2005"},{"key":"10.1016\/j.nbd.2007.05.003_bib25","doi-asserted-by":"crossref","first-page":"25859","DOI":"10.1074\/jbc.R200001200","article-title":"Combinatorial ganglioside biosynthesis","volume":"277","author":"Kolter","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.05.003_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02641015","article-title":"The chemistry of gangliosides: a review","volume":"43","author":"Ledeen","year":"1966","journal-title":"J. Am. Oil Chem. Soc."},{"key":"10.1016\/j.nbd.2007.05.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jss.400080102","article-title":"Ganglioside structures and distribution: are they localized at the nerve ending?","volume":"8","author":"Ledeen","year":"1978","journal-title":"J. Supramol. Struct."},{"key":"10.1016\/j.nbd.2007.05.003_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-2275(20)43153-0","article-title":"Gangliosides in subacute sclerosing leukoencephalitis: isolation and fatty acid composition of nine fractions","volume":"9","author":"Ledeen","year":"1968","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0006-8993(86)90420-8","article-title":"Immunocytochemical localization of GD3 ganglioside to astrocytes in murine cerebellar mutants","volume":"374","author":"Levine","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","article-title":"A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder","volume":"103","author":"Liu","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2007.05.003_bib31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/nbt1296-1675","article-title":"Expression monitoring by hybridization to high-density oligonucleotide arrays","volume":"14","author":"Lockhart","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2007.05.003_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-2275(20)37906-2","article-title":"Analysis of brain lipids by high performance thin-layer chromatography and densitometry","volume":"24","author":"Macala","year":"1983","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0959-4388(96)80097-3","article-title":"Huntington's disease: translating a CAG repeat into a pathogenic mechanism","volume":"6","author":"MacDonald","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nbd.2007.05.003_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2007.05.003_bib35","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197410312911802","article-title":"GM3 (hematoside) sphingolipodystrophy","volume":"291","author":"Max","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2007.05.003_bib36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2007.05.003_bib37","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1111\/j.1471-4159.1971.tb00204.x","article-title":"Enzyme alterations and lipid storage in three variants of Tay\u2013Sachs disease","volume":"18","author":"Sandhoff","year":"1971","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib38","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-4157(96)00011-1","article-title":"The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodies","volume":"1286","author":"Schwarz","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2007.05.003_bib39","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.1074\/jbc.274.32.22581","article-title":"Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore","volume":"274","author":"Scorrano","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.05.003_bib40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/BF00484350","article-title":"Heterosis for brain myelin content in mice","volume":"18","author":"Seyfried","year":"1980","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.nbd.2007.05.003_bib41","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4684-1200-0_15","article-title":"Cellular localization of gangliosides in the mouse cerebellum: analysis using neurological mutants","volume":"174","author":"Seyfried","year":"1984","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2007.05.003_bib42","first-page":"3","article-title":"Ganglioside GD3: structure, cellular distribution, and possible function","volume":"68","author":"Seyfried","year":"1985","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0022-2275(20)41284-2","article-title":"Isolation and characterization of human liver hematoside","volume":"19","author":"Seyfried","year":"1978","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1471-4159.1978.tb12428.x","article-title":"Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures","volume":"31","author":"Seyfried","year":"1978","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1471-4159.1984.tb12856.x","article-title":"Cellular distribution of gangliosides in the developing mouse cerebellum: analysis using the staggerer mutant","volume":"43","author":"Seyfried","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2007.05.003_bib46","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.05.003_bib47","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/11.17.1953","article-title":"Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses","volume":"11","author":"Sipione","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2007.05.003_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4684-7844-0_2","article-title":"Ganglioside designation","volume":"125","author":"Svennerholm","year":"1980","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.nbd.2007.05.003_bib49","doi-asserted-by":"crossref","first-page":"XI","DOI":"10.1016\/S0079-6123(08)61935-4","article-title":"Designation and schematic structure of gangliosides and allied glycosphingolipids","volume":"101","author":"Svennerholm","year":"1994","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib50","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0006-3002(61)90460-7","article-title":"Composition of brain gangliosides","volume":"53","author":"Svennerholm","year":"1961","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2007.05.003_bib51","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","article-title":"Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system","volume":"93","author":"Takamiya","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.05.003_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(78)90102-8","article-title":"Alterations in the composition of brain lipids in patients with Creutzfeldt\u2013Jakob disease","volume":"35","author":"Tamai","year":"1978","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2007.05.003_bib53","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/jnr.21046","article-title":"Striatal specificity of gene expression dysregulation in Huntington's disease","volume":"84","author":"Thomas","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2007.05.003_bib54","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1523\/JNEUROSCI.3355-05.2005","article-title":"Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease","volume":"25","author":"Valenza","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2007.05.003_bib55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.05.003_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","article-title":"Neuropathological classification of Huntington's disease","volume":"44","author":"Vonsattel","year":"1985","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2007.05.003_bib57","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0300-9084(01)01308-6","article-title":"Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration","volume":"83","author":"Vyas","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.nbd.2007.05.003_bib58","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.0407785102","article-title":"Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions","volume":"102","author":"Yamashita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2007.05.003_bib59","doi-asserted-by":"crossref","first-page":"14628","DOI":"10.1074\/jbc.270.24.14628","article-title":"Molecular cloning of Sia alpha 2,3 Gal beta 1,4GlcNAc alpha 2,8-sialyltransferase from mouse brain","volume":"270","author":"Yoshida","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2007.05.003_bib60","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1194\/jlr.R300020-JLR200","article-title":"Regulation of ganglioside biosynthesis in the nervous system","volume":"45","author":"Yu","year":"2004","journal-title":"J. Lipid Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996107001076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:01:47Z","timestamp":1760850107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996107001076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0969996107001076"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2007.05.003","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycolipid and ganglioside metabolism imbalances in Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2007.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}